Insider Transactions in Q3 2024 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
19,702
-5.72%
|
$1,674,670
$85.49 P/Share
|
|
Sep 09
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.34%
|
$360,000
$36.05 P/Share
|
|
Aug 15
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,409
-6.16%
|
$418,855
$95.23 P/Share
|
|
Aug 05
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
41,913
-54.69%
|
$3,897,909
$93.19 P/Share
|
|
Aug 05
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
41,913
+9.21%
|
$2,472,867
$59.11 P/Share
|
|
Jul 05
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
3,850
-8.09%
|
$427,350
$111.2 P/Share
|
|
Jul 05
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,850
+7.48%
|
$207,900
$54.13 P/Share
|
|
Jul 03
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
8,817
-16.77%
|
$978,687
$111.29 P/Share
|
|
Jul 03
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,817
+14.36%
|
$476,118
$54.13 P/Share
|
|
Jul 01
2024
|
Christina Rossi CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,625
+11.52%
|
-
|
|
Jul 01
2024
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+13.18%
|
-
|